CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES:
Net income	$ 180,550	$ 169,075	$ 133,892
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	118,299	119,836	116,031
Non-cash in-process research and development expense	0	0	519
Non-cash impairment charges	0	2,754	0
Deferred income tax (benefit) provision	(4,585)	(2,755)	(64,138)
Share-based compensation	27,725	36,210	19,590
Amortization of debt issuance costs and expenses associated with debt refinancing	6,845	7,030	12,076
Non-cash lease expense	2,816	3,834	2,955
Accretion of bond issuance discount	0	0	15,415
Loss (Gain) on disposal of property and equipment and construction in-progress	(6,813)	2,240	7,855
Gain from the sale of businesses	(644)	(41,798)	0
Change in fair value of contingent consideration and others	(20,304)	(2,162)	951
Changes in assets and liabilities:
Accounts receivable	(33,905)	7,265	52,105
Inventories	(29,124)	5,374	(48,348)
Prepaid expenses and other current assets	8,612	(21,143)	1,632
Other non-current assets	(2,182)	7,875	13,735
Accounts payable, accrued expenses and other current liabilities	17,343	32,874	(57,512)
Contract liabilities	4,274	28	(37)
Other non-current liabilities	(4,438)	(14,110)	(2,889)
Net cash provided by operating activities	264,469	312,427	203,832
INVESTING ACTIVITIES:
Purchases of property and equipment	(42,343)	(48,022)	(38,890)
Proceeds from sale of business	23,960	190,468	0
Acquired in-process research and development and intangibles	(4,742)	(58)	(25,000)
Cash paid for business acquisitions, net of cash acquired	(51,509)	(303,910)	0
Proceeds from sales of property and equipment	11,145	3	3,657
Net proceeds (payments) on swaps designated as net investment hedges	4,909	76	(7,840)
Net cash used in investing activities	(58,580)	(161,443)	(68,073)
FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness	40,750	25,500	171,500
Payments on debt	(148,550)	(125,500)	(441,000)
Purchase of option hedge on convertible notes	0	0	(104,248)
Proceeds from convertible notes issuance	0	0	575,000
Proceeds from sale of stock purchase warrants	0	0	44,563
Payment of debt issuance costs	0	(249)	(24,347)
Purchase of treasury stock	(125,000)	0	(100,000)
Proceeds from exercised stock options	5,465	6,824	5,232
Cash taxes paid in net equity settlement	(24,618)	(4,801)	(5,075)
Net cash (used in) provided by financing activities	(251,953)	(98,226)	121,625
Effect of exchange rate changes on cash and cash equivalents	(10,723)	(9,476)	13,871
Net increase (decrease) in cash and cash equivalents	(56,787)	43,282	271,255
Cash and cash equivalents at beginning of period	513,448	470,166	198,911
Cash and cash equivalents at end of period	$ 456,661	$ 513,448	$ 470,166